Previous study indicated that NPC patients carrying lncRNA GAS5 rs2067079 CT genotypes were more likely to experience chemoradiotherapy induced severe myelosuppression and severe neutropenia [19]. The gene discussed is GAS5; the disease is nasopharyngeal carcinoma.